CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
about
Adverse effects of biologics: a network meta-analysis and Cochrane overviewExtranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapyApproach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentaryCentral nervous system prophylaxis in diffuse large B-cell lymphoma.Primary cardiac lymphoma with isolated parenchymal central nervous system relapse: report of two cases and review of the literature.How to facilitate early diagnosis of CNS involvement in malignant lymphoma.Bilateral subdural hygromas following administration of intrathecal methotrexate chemotherapy.Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experienceAbsolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphomaPhase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoDiffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse.Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group CentersA multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphomaCentral nervous system recurrence of systemic lymphoma in the era of stem cell transplantation--an International Primary Central Nervous System Lymphoma Study Group project.Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trialPhase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas.Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group.Central nervous system involvement in AIDS-related lymphomasPrediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography.Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvementSecondary infiltration of the central nervous system in patients with diffuse large B-cell lymphomaNew risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).Management of relapsed-refractory diffuse large B cell lymphoma.Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study.Unresolved issues in diffuse large B-cell lymphomas.Anticancer therapies and CNS relapse: overcoming blood-brain and blood-cerebrospinal fluid barrier impermeability.Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma.Central nervous system involvement in T-cell lymphoma: A single center experience.Clinical challenges of primary diffuse large B-cell lymphoma of the dura: case report and literature review.Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis.XVI. CNS prophylaxis in aggressive lymphomas: for whom and how.Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era.Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).Isolated recurrence of secondary CNS lymphoma: case report and literature review.
P2860
Q24234197-15ADC010-7C6B-4D13-A03F-5848B186FBF9Q24631961-F690DEAF-5AF7-411F-9058-5F7E87741CE1Q28088365-2DCEBDD4-059B-4773-B8FD-A06B5299DAD2Q30251550-9FD00DB5-1814-4887-A20D-5670D936EDD5Q30867952-167A814F-9FAA-47D2-A70C-4DF953BB4C4FQ31133442-2D6B6A61-4E52-4843-AF9B-0D1489D52F7CQ33423067-7F5CECF4-14F1-473B-A784-27EA5E196BACQ33828585-15E9537A-DE7A-4351-BE2E-5E92FDB7506FQ33859877-C641E8B1-294C-4CEF-AC00-5FD15E526BD4Q34798062-08F4E238-16E3-41C1-9B8D-4EBCD53CB777Q34943963-5311C1A9-3056-4FBC-94C3-7861D50D0487Q35082516-72699FDF-7B57-4C86-B108-A60DAC264F19Q35123219-3839B5ED-720D-49F7-8FDD-4B7CF81F5D43Q35678403-5A114535-0AB8-49C7-B7E7-AB29D3A642A9Q36805893-20279AE1-ED8A-4DC3-986B-12CC45D9CE5AQ36859222-75ADB618-C5B1-4967-9BE3-873F154A5EDDQ36862405-61B58DC1-B927-4BC4-9B28-2CB68E1089FEQ36934293-DD332DC4-FFDF-4026-AB33-9D1FB3B018D5Q36989459-58F1DB74-2A83-493E-BE6D-0517F7F3D457Q37026232-4F6418E4-6246-499C-89C8-C4466A0EC019Q37155119-F6FCCD1F-E363-4BC3-8124-24431A1F777EQ37212614-054F0041-DA6C-458D-91A0-6C5D7743C058Q37254890-CCD5BF74-F54C-429C-97EB-B8294ADC7B3AQ37618814-E8BC90FF-9F33-4EE6-84BB-79C8917CD0D3Q37644528-3B77E555-1BA9-497E-8CF9-258B8549B14AQ37654010-389C3F50-36BF-4FE8-BB5A-5F578EC77908Q37687767-9C8B98FF-044C-49B6-97C2-28D05D7A1869Q37705417-4FB2784D-73F0-4E5A-B948-F702CC65D880Q37724215-D2CCC25C-9E1D-44AF-AE4C-82E8E2C3A378Q37731964-B4F019DE-1F63-426D-B08E-BCFADFB95F92Q37733139-2E16650F-D74B-4199-A07B-BBC970DDB39EQ37956322-4B0C53AB-F5CC-4967-91BF-CA9B0B6AED86Q38011619-1BF5BAB1-C926-496D-B921-22A83DD6CDB3Q38031010-16989ED3-8DFD-4027-8B64-2E95CD9E5178Q38047385-3DC1B993-64B4-4F50-9C67-DDD32817BAADQ38112455-1DC5B1B6-D9FE-4ED9-B22E-265881927A26Q38115237-C0160004-B60C-4472-8057-A053E44C1FE1Q38167036-EC97AB27-C00D-4C83-9A82-2BC4D3B7D66DQ38210131-65A837F6-CEED-4850-B218-7666A077BBDCQ38235962-92D4F9A0-F90B-40CF-85FF-84BA9266DD98
P2860
CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
CNS events in elderly patients ...... Lymphoma Study Group (DSHNHL).
@en
CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy
@nl
type
label
CNS events in elderly patients ...... Lymphoma Study Group (DSHNHL).
@en
CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy
@nl
prefLabel
CNS events in elderly patients ...... Lymphoma Study Group (DSHNHL).
@en
CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy
@nl
P2093
P1433
P1476
CNS events in elderly patients ...... Lymphoma Study Group (DSHNHL).
@en
P2093
Markus Loeffler
Norbert Schmitz
Samira Zeynalova
Volkmar Boehme
P304
P356
10.1182/BLOOD-2008-10-182253
P407
P577
2009-01-14T00:00:00Z